Hemophilia A
"Hemophilia A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
Descriptor ID |
D006467
|
MeSH Number(s) |
C15.378.100.100.500 C15.378.100.141.500 C15.378.463.500 C16.320.099.500
|
Concept/Terms |
Hemophilia A- Hemophilia A
- Hemophilia As
- Hemophilia, Classic
- Hemophilia
- Hemophilia A, Congenital
- Congenital Hemophilia A
- Congenital Hemophilia As
- Hemophilia As, Congenital
- Classic Hemophilia
- Classic Hemophilias
- Hemophilias, Classic
- Haemophilia
Autosomal Hemophilia A- Autosomal Hemophilia A
- As, Autosomal Hemophilia
- Autosomal Hemophilia As
- Hemophilia A, Autosomal
- Hemophilia As, Autosomal
Factor VIII Deficiency- Factor VIII Deficiency
- Factor 8 Deficiency, Congenital
- Factor VIII Deficiency, Congenital
- Deficiency, Factor VIII
|
Below are MeSH descriptors whose meaning is more general than "Hemophilia A".
Below are MeSH descriptors whose meaning is more specific than "Hemophilia A".
This graph shows the total number of publications written about "Hemophilia A" by people in this website by year, and whether "Hemophilia A" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 | 1998 | 2 | 0 | 2 | 2000 | 1 | 0 | 1 | 2007 | 1 | 1 | 2 | 2011 | 0 | 1 | 1 | 2013 | 1 | 1 | 2 | 2014 | 1 | 0 | 1 | 2015 | 1 | 1 | 2 | 2016 | 2 | 0 | 2 | 2017 | 2 | 0 | 2 | 2018 | 5 | 0 | 5 | 2019 | 5 | 0 | 5 | 2020 | 9 | 0 | 9 | 2021 | 8 | 0 | 8 | 2022 | 3 | 0 | 3 | 2023 | 8 | 0 | 8 | 2024 | 6 | 0 | 6 | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hemophilia A" by people in Profiles.
-
Jiang D, Wang M, Wheeler AP, Croteau SE. 2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders. Am J Hematol. 2025 Apr; 100(4):666-684.
-
Hermans C, Skinner MW, Gentile B, Lim E, Minhas M, Moreno K, Tzeng E, Buckner TW. Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY Studies. Haemophilia. 2025 Jan; 31(1):87-98.
-
Chowdary P, Angchaisuksiri P, Apte S, Astermark J, Benson G, Chan AKC, Jim?nez Yuste V, Matsushita T, H?gh Nielsen AR, Sathar J, Sutton C, ?aulyte Trakymiene S, Tran H, Villarreal Martinez L, Wheeler AP, Windyga J, Young G, Thaung Zaw JJ, Eichler H. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial. Lancet Haematol. 2024 Dec; 11(12):e891-e904.
-
Mah J, Robertson C, Mah N, Roybal J, Thornhill D, Funk S, Manco-Johnson MJ, Carollo J, Gaffney BMM, Warren BB. Joint reaction and simulated muscle forces during squatting and walking in persons with hemophilia. Clin Biomech (Bristol). 2024 Dec; 120:106361.
-
Kempton CL, Guasch SA, Buckner TW, Mattis S, Fedewa SA. Differences and similarities in patient-reported outcomes among men and women with haemophilia. Haemophilia. 2024 Nov; 30(6):1383-1392.
-
Jewell MP, Ashour Z, Baird CH, Manco Johnson M, Warren BB, Wufsus AR, Pallini C, Dockal M, Kjalke M, Neeves KB. Concizumab improves clot formation in hemophilia A under flow. J Thromb Haemost. 2024 Sep; 22(9):2438-2448.
-
Mrakotsky C, Walsh KS, Buranahirun Burns C, Croteau SE, Markert A, Geybels M, Hannemann C, Rajpurkar M, Shapiro KA, Wilkening GN, Ventola P, Cooper DL. The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia. J Pediatr. 2024 Sep; 272:114089.
-
Zemplenyi A, Leonard J, DiStefano MJ, Anderson KE, Wright GC, Mendola ND, Nair K, McQueen RB. Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid. Pharmacoeconomics. 2024 Mar; 42(3):319-328.
-
Wheeler AP, Lim MY, Huguelet PS, Jaffray J, Staber JM, Funkhouser K, Carpenter SL, Weyand AC. Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers. Am J Hematol. 2023 12; 98(12):E399-E402.
-
Tarantino MD, Hardesty B, Metjian A, Ortel TL, Chen J, Badejo K, Ma A, Cuker A, Rajasekhar A, Friedman KD, Janbain M. Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study. Haemophilia. 2023 Sep; 29(5):1259-1268.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|